The Actavis-Forest merger, the proposed Valeant-Allergan merger and today's Novartis-Glaxo deal constitute a warning to large pharmaceutical companies that as they engage in layoffs, downsizings, contractions and divestiture, other, more nimble companies, are acquiring, merging and growing to take over leadership in the drug and medical device industries.